A National Study to Determine the Prevalence of Drug Resistance in Newly Discovered Previously Untreated Tuberculosis Patients As Well As in Retreatment Cases
Overview
Affiliations
Estimating tuberculosis drug resistance amplification rates in high-burden settings.
Karmakar M, Ragonnet R, Ascher D, Trauer J, Denholm J BMC Infect Dis. 2022; 22(1):82.
PMID: 35073862 PMC: 8785585. DOI: 10.1186/s12879-022-07067-1.
Incidence of positive tuberculin tests by age and place of birth: a study.
Mountifield J Can Fam Physician. 2011; 28:1267-70.
PMID: 21286118 PMC: 2306439.
Drug resistance study of Mycobacterium tuberculosis in Canada, February 1, 1993 to January 31, 1994.
Farzad E, Holton D, Long R, Fitzgerald M, Laszlo A, Njoo H Can J Public Health. 2000; 91(5):366-70.
PMID: 11089291 PMC: 6980084.
Globalization of tuberculosis.
Fanning E CMAJ. 1998; 158(5):611-2.
PMID: 9526475 PMC: 1229004.
Antituberculous drug resistance in Manitoba from 1980 to 1989.
Long R, Manfreda J, Mendella L, Wolfe J, Parker S, Hershfield E CMAJ. 1993; 148(9):1489-95.
PMID: 8477367 PMC: 1491866.